These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32588036)

  • 21. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
    Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
    Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic and Functional Heart Abnormalities Associated to High Modified Tei Index in Hypertensive Patients.
    Tissera G; Piskorz D; Citta L; Citta N; Citta P; Keller L; Bongarzoni L; Mata L; Tommasi A
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):373-380. PubMed ID: 27623974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler study in echocardiographic practice.
    Cuspidi C; Negri F; Sala C; Valerio C; Mancia G
    Blood Press; 2012 Feb; 21(1):24-30. PubMed ID: 21992028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy.
    Le TT; Lim V; Ibrahim R; Teo MT; Bryant J; Ang B; Su B; Aw TC; Lee CH; Bax J; Cook S; Chin CWL
    Eur Heart J Cardiovasc Imaging; 2021 May; 22(6):670-679. PubMed ID: 32255186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LV mass index significantly impacts on patient and renal outcomes in patients with coronary artery bypass grafting and poor left-ventricular function.
    Lin CL; Hsu PY; Yang CT; Yang HY; Yang TY; Huang WH; Huang CC
    Ren Fail; 2003 Mar; 25(2):287-95. PubMed ID: 12739835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of abnormal left ventricular geometry in patients without cardiovascular disease through machine learning: An ECG-based approach.
    Angelaki E; Marketou ME; Barmparis GD; Patrianakos A; Vardas PE; Parthenakis F; Tsironis GP
    J Clin Hypertens (Greenwich); 2021 May; 23(5):935-945. PubMed ID: 33507615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geometrical and functional changes of left heart in adults with prehypertension and hypertension: a cross-sectional study from China.
    Li T; Yang J; Guo X; Chen S; Sun Y
    BMC Cardiovasc Disord; 2016 May; 16():114. PubMed ID: 27234840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos.
    Mehta H; Armstrong A; Swett K; Shah SJ; Allison MA; Hurwitz B; Bangdiwala S; Dadhania R; Kitzman DW; Arguelles W; Lima J; Youngblood M; Schneiderman N; Daviglus ML; Spevack D; Talavera GA; Raisinghani A; Kaplan R; Rodriguez CJ
    Circ Heart Fail; 2016 Apr; 9(4):e002733. PubMed ID: 27048764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Blood Pressure Control Level With Left Ventricular Morphology and Function and With Subclinical Cerebrovascular Disease.
    Nakanishi K; Jin Z; Homma S; Elkind MSV; Rundek T; Tugcu A; Sacco RL; Di Tullio MR
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28757483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of different ranges of systolic blood pressure on left ventricular structure and diastolic function in a Chinese population: a cross-sectional population-based Shunyi study.
    Yongtai L; Jinzhi L; Lixin Z; Feifei Z; Dingding Z; Zhuang T; Yanlin Z; Wei C; Hua B; Hui W; Yicheng Z; Liying C; Zhengyu J; Zhang S
    BMJ Open; 2019 Sep; 9(8):e028398. PubMed ID: 31481369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Impact of Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease.
    Ogawa T; Nitta K
    Contrib Nephrol; 2018; 195():81-91. PubMed ID: 29734153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
    Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal left ventricular longitudinal function assessed by echocardiographic and tissue Doppler imaging is a powerful predictor of diastolic dysfunction in hypertensive patients: the SPHERE study.
    Dini FL; Galderisi M; Nistri S; Buralli S; Ballo P; Mele D; Badano LP; Faggiano P; de Gregorio C; Rosa GM; Ciavarella M; De Marco E; Borruso E; Marti G; Mondillo S; Marino PN;
    Int J Cardiol; 2013 Oct; 168(4):3351-8. PubMed ID: 23647589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    Kagiyama N; Piccirilli M; Yanamala N; Shrestha S; Farjo PD; Casaclang-Verzosa G; Tarhuni WM; Nezarat N; Budoff MJ; Narula J; Sengupta PP
    J Am Coll Cardiol; 2020 Aug; 76(8):930-941. PubMed ID: 32819467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.